Introduction
The coordinated signaling generated through extracellular matrix (ECM) adhesion and growth factors is essential for normal epithelial cell survival, growth and proliferation (Miranti and Brugge, 2002; Cabodi et al., 2004) . Depriving normal adherent cells from ECM anchorage can lead to cellular stress that eventually may initiate programmed cell death or anoikis (Frisch and Screaton, 2001; Gilmore, 2005) . However, during tumor progression, malignant cells are generally capable of overcoming the lack of proper cellular adhesion to the ECM and nutrient deprivation. Under these microenvironmental stress conditions, cells must adapt specific signaling pathways that promote their survival, growth and tumor dormancy (Alt-Holland et al., 2005; Ranganathan et al., 2006; Aguirre-Ghiso, 2007) . The cellular mechanisms controlling these pathways remain complex and poorly understood.
Cell spheroids or multicellular aggregates (MCA) represent an anchorage-independent culture model designed to recapitulate the in vivo three-dimensional solid tumors (Bates et al., 2000) . The formation of these aggregates is dependent on the engagement of cellular adhesion receptors, such as the cadherins. From this three-dimensional model system, it is strongly evident that the extensive intercellular adhesions can mediate signals to circumvent ECM dependency and promote survival and growth regulating response (Bates et al., 2000; Santini et al., 2000) . Insights gained from these studies provide an additional facet in understanding the adverse nature of the tumor microenvironment and holds a promising model system for therapeutic drug development (Alt-Holland et al., 2005; Friedrich et al., 2007) .
Earlier we showed that ligand-independent epidermal growth factor receptor (EGFR) activation acts as a survival signal in squamous cell carcinoma MCAs (Kantak and Kramer, 1998; Shen and Kramer, 2004) . This work demonstrates that EGFR-mediated survival effects were primarily through activation of ERK, but not AKT. EGFR is one of the receptor-tyrosine kinases that can trigger phosphatidylinositol 3 0 -kinase (PI3K)-mediated AKT activation (Manning and Cantley, 2007; Engelman, 2009) . Despite activated EGFR, phospho-AKT was neither detected nor did specific chemical inhibitors of AKT induce cell death in MCA . This phenomenon may represent an example of context-dependent EGFR-mediated PI3K/ AKT signaling. Defining the underlying cellular events involved here may provide insights on the mechanism by which EGFR modulates tumor cell survival and growth in the adverse and dynamic microenvironment encountered during tumor progression.
In this report, we have examined the mechanism of ligand-independent EGFR signaling using the squamous cell carcinoma three-dimensional model. To mimic the physiologically relevant growth promoting or restricting environment, these studies were performed in serum-stimulated and -starved conditions, respectively. We found that EGFR signaling in serum-starved MCA failed to support cyclin D1 protein expression and cell proliferation. This was in contrast to serum-stimulated MCAs in which cyclin D1 expression was positively regulated through EGFR-mediated ERK and AKT activation. Analysis of EGFR activation in serumstarved MCA as well as use of interleukin-2 receptor (ILR)-EGFR-chimera revealed that depending on the mode of activation, EGFR can act differentially in its ability to couple the Gab1/PI3K/AKT signaling module. Thus, we hypothesize that by modulating the PI3K/ AKT pathway; microenvironment-dependent EGFR signaling may regulate cyclin D1 expression and the cellular proliferative response.
Results
Serum starvation suppresses cyclin D1 expression and proliferation in anchorage-independent MCA To study cellular growth mechanisms under microenvironmental stress conditions, we used the MCA model (Kantak and Kramer, 1998; Shen and Kramer, 2004) and generated MCAs in serum-stimulated and -starved conditions for 24 h. Figure 1a shows the presence of strong cyclin D1 protein in serum-stimulated MCA, but only a low level in serum-deprived MCA. The expression of cyclin D1 did not show a significant serum dependency in monolayer culture. Under identical conditions, the BrdU uptake in serum-starved MCAs was about 4%, whereas serum stimulation showed increased labeling of B19% (Figure 1b) . However, we did not detect any significant difference in cell viability or the ability to adhere and scatter on tissue culture plates between the serum-stimulated and -starved MCAs (Supplementary Figures 1A and B) . Together, these results show that serum deprivation suppresses cyclin D1 expression and proliferation in MCA.
Serum-deprived EGFR activation in MCA is not sufficient for cyclin D1 expression and proliferation To investigate the possible function of EGFR activation in modulating cell growth under stress-induced conditions, serum-deprived MCAs were analyzed for EGFR phosphorylation. EGFR activation was evident as cells progressed from loose to more compact MCAs, even in the absence of serum factors (Figures 1c and d) . However, the level of cyclin D1 protein expression gradually decreased, showing a significant reduction by 9 and 24 h. Concomitantly, there was a dramatic increase in p27 expression at 24 h. As expected, adherent monolayer cells continued to maintain high cyclin D1, but low p27 protein expression under serum-starved conditions. The observed loss of cyclin D1 protein expression in serumstarved MCAs after 24 h was similar to that of cells incubated as a single cell (S) suspension (Figure 1e ), which lack proliferation capabilities and eventually undergo anoikis (Kantak and Kramer, 1998) . But unlike cells in suspension, MCA displayed strong ERK phosphorylation that is consistent with our earlier report . However, the presence of serum did not seem to further enhance the ERK phosphorylation. The presence of constitutively activated ERK in MCAs seems to over-ride the serum-induced ERK activity. In contrast, only weak AKT phosphorylation was observed in MCAs and single cell suspension. As cyclin D1, an EGFR target gene, is essential for cell-cycle progression, it implies that in the absence of serum and ECM attachment, a likely ligand-independent EGFR signaling is not sufficient to promote robust cell proliferation.
To directly test ligand-independent EGFR signaling, we generated an EGFR-chimera lacking a ligand-binding region that exhibits constitutive kinase activity (Bernard et al., 1987) (Figure 2a ). As HSC-3 cells express high levels of endogenous EGFR, we used HEK293 cells that express undetectable levels of endogenous EGFR for the transfection studies. These well-characterized cells contain protein molecules necessary for EGFR signaling (Schmidt et al., 2003; Cai et al., 2006) . Analysis confirmed efficient cell surface expression of the ILR-EGFRchimera proteins (Supplementary Figure 2A) . The ILRwt chimera displayed strong phosphorylation activity resulting in ERK1/2, but not AKT phosphorylation (Figure 2b ). The ILR-DJD and ILR-DKD similar to the vector control neither exhibit any phosphorylation nor did it transduce downstream ERK1/2 phosphorylation. Confirming the intrinsic-kinase function of ILR-wt, an EGFR inhibitor (AG1478), but not an Src-inhibitor (SU6656), blocked phosphorylation activity of the chimera and ERK1/2 in a dose-dependent manner (Supplementary Figure 2B ; data not shown). Subsequently, we used ILR-wt as a ligand-independent active EGFR and the ILR-DJD as an inactive chimera control.
We next tested the ILR-wt construct on the expression of cyclin D1. The full-length EGFR (FL-wt)-transfected HEK293 cells stimulated with EGF, as well as normal cells grown in the presence of serum, effectively induced the expression of cyclin D1 (Figure 2c ). However, cyclin D1 protein induction was lacking in the ILR-wt expressing cells despite the strong phosphorylation activity. Cyclin D1 expression was also not detected in the unstimulated, vector-control or ILR-DJD cells. Stimulation of FL-wt HEK293 cells with EGF modestly increased the rate of DNA synthesis, whereas the ILR-wt did not support HEK293 cell proliferation. However, after being subjected to 24 h suspension-induced apoptosis, the ILR-wt expressing cells produced about 75% cell survival compared with B30% in the vector control and ILR-DJD ( Supplementary Figures 2C and D) . These results support the observations that serum-deprived EGFR activation in MCAs, likely ligand independent, generates an effective survival signal without induction of cyclin D1 or cell proliferation.
Serum-dependent cyclin D1 expression in MCA requires EGFR signaling To study the function of EGFR signaling in regulating cyclin D1 expression in the microenvironment of cell aggregates, we used two potent EGFR inhibitors, PD168393 and AG1478 (Onishi et al., 2008) . We initially evaluated the time course of serum stimulation required for cyclin D1 expression in pre-formed MCAs. Cyclin D1 induction was evident at 3 h and expression reached a plateau at 6 h ( Figure 3A) . Whereas EGFR and ERK1/2 phosphorylation was readily detected in MCAs with or without serum, neither p-AKT activity nor cyclin D1 expression was evident in the serum-free MCAs ( Figure 3B ). However, serum stimulation induced AKT phosphorylation and showed robust induction of cyclin D1 protein (Figure 3Bg ). Inhibition of EGFR activity in 6 h MCA with either 1 or 10 mM PD168393 or AG1478 blocked serum-induced AKT and ERK1/2 phosphorylation and correlated with cyclin D1 reduction. Treatment with U0126 and LY294002 also blocked ERK1/2 and AKT phosphorylation, respec- (c) were collected, lysed and analyzed for cyclin D1 and p27 expression or immunoprecipitated (IP) and analyzed for phospho-EGFR and total EGFR. Serum-starved ML cells at 0 h (time MCA started) and 24 h (time final MCA collected) were included as controls. (e) HSC-3 cells were subjected to single cell suspension (S) or as MCA in the absence or presence of serum. After 24 h, cells were collected, lysed and processed for immunoblotting as indicated. Membranes were stripped and reprobed for total ERK1/2 and AKT. Cell lysates from serum-starved ML culture treated with EGF (10 ng/ml) for 5 min were included as a control for ERK and AKT activation. Tubulin was used as loading control wherever indicated. The results are representatives of at least three independent experiments.
tively, and led to inhibition of cyclin D1 expression (not shown). Serum stimulation also increased the cyclin D1 induction in a set of HNSCC cell lines, SCC-4, MOK-101, Ca9-22 and HSC-2 cells, although with varying efficiency. In addition, the levels of cyclin D1 expression were lowered with EGFR inhibition (Supplementary Figures 3A and B) . To confirm the specificity of EGFR, an siRNA-mediated knockdown of EGFR was used that strongly inhibited the serum-induced phosphorylation of AKT and ERK in MCAs ( Figure 3C ). Concomitantly, there was decrease in the serum-stimulated induction of cyclin D1 protein. These results imply that serum-induced cyclin D1 expression in anchorageindependent MCA is mediated primarily through EGFR, which signals upstream of PI3K and MAPK activation.
Serum-dependent cyclin D1 expression in MCA is associated with Y1086 EGFR autophosphorylation Activated EGFR in serum-starved MCA does not support cyclin D1 expression ( Figure 1 ). However, serum-stimulated cyclin D1 expression is mediated through EGFR activation (Figure 3) . To understand the mechanism, we set out to evaluate the EGFR autophosphorylation activity during serum-deprived formation of MCA. Using a panel of five phospho-specific EGFR antibodies, we observed low-level phosphorylation of EGFR-tyrosine residues during the initial 3 h of culture (Figure 4a) . However, at 6 and 24 h, enhanced phosphorylation was detected at tyrosine residues Y845, Y1068, Y1148 and Y1173 that correlated with the progressed formation of compacted MCAs. Surprisingly, residue Y1086 showed minimal phosphorylation under the same conditions. Monolayer cell controls showed that EGF readily induced strong phosphorylation at all tyrosine sites including residue Y1086. This confirmed the specificity of the antibodies, which have also been successfully used by others (Moro et al., 2002) . To rule out a defective Y1086 residue in the aggregates, MCAs were stimulated with EGF for varying time periods (Figure 4b ). EGF treatment showed robust induction of phosphorylation at residue Y1086 at all time points. Next, we tested whether inefficient EGFR-Y1086 autophosphorylation was associated with reduced cyclin D1 levels in serum-starved MCAs. Immunoblotting revealed that residues Y845, Y1068, Y1148 and Y1173 were readily phosphorylated in both serum-deprived and -stimulated MCAs (Figure 4c ). However, residue Y1086 phosphorylation and cyclin D1 expression was only weakly detectable in serumdeprived MCAs. Exposure to low and moderate serum (1 and 10% fetal bovine serum (FBS)) seemed to induce the phosphorylated level of Y1086, and this correlated with the enhanced cyclin D1 expression. As expected, PD168393 and AG1478 effectively blocked the EGFR phosphorylation pattern and cyclin D1 induction. Though additional studies are needed to further define the precise mechanism by which serum factors induce EGFR activation, our results show that in serumdeprived MCA, the EGFR activation produces an inefficient receptor autophosphorylation pattern.
Ligand-independent EGFR activation mediates selective tyrosine autophosphorylation To further evaluate the unique ligand-independent EGFR autophosphorylation pattern observed above, we used a series of assays using HSC-3 and HEK293 cells. Initially, the ability of hE-cad/Fc beads to induce E-cadherin recruitment on HSC-3 monolayer cells and cluster with aggregating cells on poly-HEMA substrate was evaluated ( Supplementary Figures 4A and B) . As cell aggregation progressed between 3 and 6 h, we incubated HSC-3 cells with hE-cad/Fc-or bovine serum albumin (BSA)-coated beads for 4 h before analysis. The hE-cad/Fc beads induced enhanced EGFR phosphorylation as compared with control BSA-coated beads, but relatively at lower level compared with EGF-treated cells ( Figure 5A ). Cells treated with hE-cad/Fc beads displayed phosphorylation activity at residue Y845, Y1148 and Y1173, but Y1086-autophosphorylation remained at background levels ( Figure 5B ). Furthermore, in a Ca 2 þ -switch assay, we observed the phosphorylation at Y845, Y1068, Y1148 and Y1173 as cells formed Ca 2 þ -induced cell-cell contact ( Figure 5C ). However, Y1086 phosphorylation was not detected even after prolong X-ray film exposure. Yet, EGF treatment induced strong autophosphorylation at all residues including Y1086.
HEK293 cells co-expressing EGFR and E-cadherin displayed EGFR phosphorylation, but not in cells expressing EGFR alone on 30 min seeding on culture dish (Supplementary Figure 4C) . On further analysis, Figure 3 were incubated in DMEM containing no serum or with 1 or 10% FBS. PD168393 and AG1478 (EGFR inhibitors) were included at 1 mM to MCAs supplemented with 10% FBS. After 6 h, MCAs were collected, lysed and processed for immunoblotting as indicated. A representative membrane was stripped and reprobed with anti-EGFR. Tubulin was monitored for equivalent protein load. Representative result from three independent experiments is shown.
we observed that residues Y845, Y1068, Y1148 and Y1173 were readily autophosphorylated, whereas residue Y1086 phosphorylation was barely detectable ( Figure 5D ). The HEK293-EGFR cells treated with EGF showed strong Y1086 phosphorylation. Next, we examined the autophosphorylation status in the ILR-wt chimera. Phosphorylation at residues Y845, Y1068, Y1143 and Y1173 was readily detected in the ILR-wt and EGF-treated FL-wt expressing cells ( Figure 5E , a, b, d and e). However, autophosphorylation at residue Y1086 of constitutive active ILR-wt was consistently weak or absent (Figure 5Ec ). Taken together, these results support the observations made from the MCA experiments that ligand-independent EGFR activation induces unique autophosphorylation pattern.
Ligand-independent EGFR activation fails to recruit Gab1/PI3K/AKT signaling complex The results thus far indicate that MCAs require efficient and promiscuous EGFR autophosphorylation, with concurrent AKT and ERK activation to induce cyclin D1 expression under anchorage-independent conditions. This suggested a mechanistic relationship between inefficient EGFR autophosphorylation and the failure to induce AKT activation. We found that in EGF or serum-stimulated MCAs, EGFR co-immunoprecipitated with the PI3K regulatory p85 subunit; and this association correlated with the phosphorylation of EGFR-Y1086 and AKT (Figure 6a ). In contrast, under serum-starved conditions, neither p85 immunoreactivity nor AKT activation was detected. Interestingly, EGFR co-immunoprecipitated Shc and Grb2 independent of Figure 6 Ligand-independent EGFR activation is unable to recruit the Gab-1/p85/AKT signaling complex. (a) Pre-formed MCAs as in Figure 3 were incubated in DMEM containing either no serum or 10% FBS containing either EGF (10 ng/ml) or 1 mM PD168393. After 6 h, MCAs were collected and lysed, and about 250 mg of protein from each condition were used for immunoprecipitation (IP) with 2 mg control mouse IgG or anti-EGFR. The IP was then analyzed by immunoblotting as indicated. Cell lysates (CL) were analyzed with anti-p-AKT (stripped and reprobed with anti-AKT). (b) HEK293 cells expressing the various indicated constructs were lysed and IP with anti-Flag. The IP was then analyzed by immunoblotting as indicated. FL-wt expressing cells were stimulated with EGF (10 ng/ ml) for 10 min (c) Pre-formed HSC-3 MCAs incubated as in (a) were lysed, IP with anti-Gab1 and then analyzed with anti-pY20 (phosphotyrosine). The membrane was stripped and reprobed for total Gab-1. CL was also analyzed for the phospho-EGFR status.
(d) HEK293 cells expressing the various constructs as indicated were lysed and IP with anti-Gab1 and analyzed with anti-pY20. The membrane was stripped and reprobed for total Gab1. CL was also analyzed for phospho-EGFR or total EGFR to confirm expression of the constructs. FL-wt expressing cells were stimulated with EGF (10 ng/ml) for 10 min. serum stimulation. This complex formation was, however, at lower levels when compared with EGF induction. Expectedly, PD168393 treatment inhibited serum-stimulated EGFR-Y1086 and AKT phosphorylation and reduced the association of Shc and Grb2 with EGFR. Similarly, HEK293 cells expressing FL-wt treated with EGF induced strong EGFR phosphorylation and co-precipitated p85, Shc and Grb2. Interestingly, the ILR-wt chimera failed to associate with p85, as did the vector control and the inactive ILR-DJD chimera (Figure 6b ). However, ILR-wt was strongly phosphorylated and efficiently co-precipitated Shc and Grb2.
The adaptor protein Gab1 is phosphorylated during EGFR-mediated PI3K/AKT signaling (Holgado-Madruga et al., 1996; Mattoon et al., 2004) . In HSC-3 MCA, Gab1 was tyrosine phosphorylated on serum stimulation with or without EGF treatment, and this effect was totally abolished by PD168393 (Figure 6c ). Remarkably, there was no evidence of Gab1 phosphorylation activity from serum-starved MCAs, despite having EGFR in its active phosphorylated form. To further confirm this observation, we analyzed HEK293 cells expressing the ILR-wt. Whereas FL-wt EGFR cells stimulated with EGF induced strong Gab1 phosphorylation, the ILR-wt cells failed to do so and was similar to the vector, FL-wt (untreated) or ILR-DJD cells (Figure 6d ). To further confirm the specificity of EGFR activation on the Gab1 phosphorylation, an siRNAmediated knockdown of EGFR was used. The knockdown of EGFR protein strongly reduced the seruminduced phosphorylation of Gab1 in MCAs (Figure 6e) . Next, to examine the function of Gab1 in the EGFRmediated AKT activation, we used siRNA to knockdown Gab1. Reducing the Gab1 expression abolished the ability of EGFR to associate with p85 in seruminduced MCAs (Figure 6f) . Analyses of the lysates show that Gab1 knockdown reduced the serum-induced AKT phosphorylation. Together, the above results clearly indicate that ligand-independent EGFR activation is not sufficient in recruiting p85 or Gab1 phosphorylation to mediate AKT signaling.
Constitutively active AKT rescues EGFR-dependent cyclin D1 expression and proliferation in serum-deprived MCA Is the suppression of cyclin D1 expression and proliferation in serum-deprived MCA a consequence of ineffective AKT signaling? We tested whether reconstitution of active AKT would restore cyclin D1 protein expression and induce proliferation in HSC-3 cells expressing GFP-tagged AKT. Initially, the constitutively active-AKT1 (CA-AKT) expression and activity were confirmed by fluorescence microscopy and immunoblotting with phospho-AKT (Supplementary Figures 5A and B) . In GFP or kinase dead (KD)-AKT expressing MCAs, cyclin D1 expression was at basal levels, but after serum stimulation, cyclin D1 were induced by over twofold (Figure 7a , GFP and KD-AKT, compare lanes 1-2). As expected, inhibition of EGFR and MAPK activity blocked the serum-induced elevation of cyclin D1 expression (Figure 7a , GFP and KD-AKT, compare lanes 3-4). In contrast, CA-AKT expression in MCA under serum-free conditions promoted cyclin D1 expression to a level comparable with serum stimulation (Figure 7a , CA-AKT, compare lanes 1-2). Interestingly, in cells expressing CA-AKT, inhibition of both EGFR and MAPK activity blocked serum-stimulated cyclin D1 protein expression. Immunoblotting indicates that the status of phosphorylated EGFR or ERK1/2 in MCA is not altered by CA-AKT expression, whether in the absence or presence of serum. The CA-AKT-mediated cyclin D1 expression in the absence of serum can also be suppressed by U0126 (Figure 7b ). This indicates that MAPK and AKT signaling co-operates to modulate cyclin D1 expression in MCA. As expression of KD-AKT showed no difference in cyclin D1 protein levels compared with control GFP, we next measured DNA synthesis in the GFP control or CA-AKT expressing MCAs. Figure 7c shows that CA-AKT potentiated BrdU incorporation by about threefold over GFP control expressing MCAs, even in serum-deprived conditions. In the CA-AKT expressing MCAs, the presence of serum did not further enhance the proliferative capability of the cells. However, inhibiting the EGFR function reverted the proliferative effect back to serum-free GFP-control levels. This parallels the cyclin D1 expression pattern indicating that activated EGFR/ERK and AKT are both essential in the control of cell proliferation in MCAs.
Discussion
The importance of normal cell dependence on the ECM in linking cyclin D1 expression to cell-cycle progression and growth in vitro is well documented (Miranti and Brugge, 2002; Walker and Assoian, 2005) . In the absence of attachment to ECM substrates, growth factor-stimulated cells are unable to induce cyclin D1. Our study with HNSCC cells, cultured as anchorageindependent MCA, show a serum-dependent cyclin D1 expression and proliferation. Notably, analysis of EGFR signaling in serum-stimulated and -starved MCA revealed that depending on the mode of activation, EGFR differentially modulate the Gab1/PI3K/ AKT signaling pathway and regulate cyclin D1 expression and proliferation.
Earlier work reported that formation of MCAs by HNSCC cells induces adhesion-mediated ligandindependent EGFR/ERK activation . Indeed, in serum-deprived MCAs, EGFR/ERK was constitutively activated, whereas AKT remained inactive. However, the presence of adhesion-mediated ligand-independent active EGFR and ERK1/2 was not sufficient to promote the cell proliferative response as suggested by the diminished cyclin D1 and increased p27 protein expressions. EGFR signaling through endocrine, autocrine and juxtacrine mechanism is known (Singh and Harris, 2005; Schneider and Wolf, 2009 ).
For example, HB-EGF-mediated juxtacrine signaling is sufficient to trigger strong AKT activation (Singh et al., 2007) . Though such mechanisms are possible, the EGFR activation in serum-deprived MCA was unable to trigger active AKT or promote cyclin D1 expression or proliferation.
Blocking EGFR function inhibits the expression of cyclin D1 and proliferation (Lenferink et al., 2001) . It is also known that EGFR-mediated cell proliferation requires integrin-mediated cell adhesion to the ECM (Kuwada and Li, 2000; Bill et al., 2004) . We found that in HNSCC cell aggregates, EGFR mediated serum-depen- dent cyclin D1 expression. In this study, we focused on the HSC-3 cells, as this HNSCC cell line, derived from a cervical lymph node metastasis of a tongue primary lesion, has been shown to retain both its in vivo tumorigenicity and metastatic potential in the nude mouse model, and has been extensively characterized for its in vitro and in vivo phenotype and responsiveness to EGFR and other growth factors (Kawano et al., 2001; Bourguignon et al., 2006; Onishi et al., 2008; Nurmenniemi et al., 2009) . The results obtained in the current studies seem relevant to HNSCC, as serum stimulation enhanced EGFR-dependent cyclin D1 induction in a panel of four other well-characterized HNSCC cell lines. Other studies in anchorage-independent cultures, using MCF10A and Ewing tumor sarcoma cells have shown that AKT, but not ERK, signaling is essential in intercellular adhesionmediated cyclin D1 expression and growth (Lawlor et al., 2002; Kang et al., 2007; Fournier et al., 2008) . Our study in HNSCC cell aggregates show that EGFR-dependent ERK and AKT activation are both important in that they act synergistically to regulate cyclin D1 expression. What is the mechanism by which activated EGFR acts differentially under the two conditions (serum stimulated versus serum starved)? We identified EGFR-Y1086 as a unique residue inefficiently autophosphorylated in the serum-deprived cell aggregates. Cells that form cell aggregates do so by forming a complex three-dimensional network of intercellular adhesions. The function of E-cadherin in mediating these cell-cell interactions and transactivation of EGFR has been established (Pece and Gutkind, 2000; Shen and Kramer, 2004) . Using several approaches involving E-cadherin and EGFR-chimera constructs, we were able to confirm the unique pattern of ligand-independent EGFR autophosphorylation.
EGFR-Y1086 is one of the major tyrosine residues located at the cytoplasmic region that is readily phosphorylated during EGFR-kinase activation. This, in turn, can mediate downstream signaling events by binding with molecules such as Grb2, Shc, Gab1, STAT3 and c-Abl (Jorissen et al., 2003; Thelemann et al., 2005) . In line with our observation of persistence ERK activity, ligand-independent EGFR activation associated with the signaling adaptor proteins, Grb2 and Shc. EGFR is known to associate with the PI3K/ p85 regulator subunit and induce PI3K-mediated AKT activation (Hu et al., 1992) . However, our findings clearly suggest that though competent in Grb2 and Shc binding and ERK activation, ligand-independent EGFR activation is unable to complex with the PI3K/AKT signaling module.
Specificity of signaling by receptor-tyrosine kinases depends on interaction with specific substrates as well as with substrates shared by other signaling-competent receptors. For example, Gab1 is a docking protein involved in the downstream signaling of many types of tyrosine receptor kinases, including EGFR (HolgadoMadruga et al., 1996; Weidner et al., 1996) . On EGFR activation, Gab1 undergo tyrosine phosphorylation and potentiate EGF-mediated activation of the PI3K/AKT pathway (LeVea et al., 2004; Mattoon et al., 2004) . To our knowledge, we show here for the first time that ligand-independent EGFR activation is unable to phosphorylate Gab1. As residue Y1068 and Y1086 of EGFR have been shown to be important for EGFR/Gab1 association (Rodrigues et al., 2000) , this finding highlights the significance of inefficient EGFR-Y1086 autophosphorylation. It warrants future work to specifically examine mutated EGFR-Y1086F and its various signaling responses. Nevertheless, it is conceivable that phosphorylation at both Y1068 and Y1086 residues is critical and essential for efficient EGFR/Gab1 associations and subsequent Gab1 phosphorylation. In serum-deprived MCAs, the lack of efficient Gab1 phosphorylation may uncouple the EGFR/PI3K/AKT activation, thereby failing to promote cyclin D1 expression and proliferation. This possibility is likely because the expression of CA-AKT was able to by-pass inefficient EGFR activation and permit cyclin D1 induction and proliferation.
EGFR mediates PI3K/AKT signaling and regulates VEGF expression in hypoxic conditions (Jiang et al., 2001; Pore et al., 2006) . Similarly, loss of EGFR function has been suggested to contribute during stress signaling induction, which in turn might influence tumor dormancy (Aguirre-Ghiso, 2007) . Under serum deprivation, tumor cell-derived factors like Clusterin can modulate the PI3K/AKT pathway to determine growth and dormancy . Thus, under unfavorable growth conditions, the ability of EGFR to regulate PI3K/AKT activation may bear important physiological implications. We hypothesize that during limited availability of nutrients/serum (for example because of poor vascularization), tumor islands of compact cell aggregates use differential EGFR signaling to uncouple the PI3K/AKT pathway yet still maintaining the ERK survival pathway. This may in turn act as an alternate mechanism to prevent cells from entering active cell-cycle progression and promote growth arrest. The presence of dormant tumor cell clusters in non-permissive microenvironment may be resistant to chemotherapy or irradiation and present significant challenges to treatment of disseminated disease. Thus, understanding such microenvironmental-derived survival pathways may suggest novel therapeutic approaches that could target dormant tumor cell in micrometastases.
Materials and methods

Reagents and cell culture conditions
The following antibodies were obtained as follows: PI3K-p85 (Millipore, Inc., Upstate/Lake Placid, NY, USA); EGFR, E-cadherin, Gab1, cyclin D1 (Santa Cruz Biotech, Santa Cruz, CA, USA); p-ERK1/2, ERK1/2, p-AKT, AKT and Grb2, and inhibitors U0126 and LY294002 (Cell Signaling Technology, Inc., Beverly, MA, USA); activated-EGFR, Shc, pY20 and tubulin (BD Biosciences, San Jose, CA, USA); phosphospecific EGFR antibodies (Biosource, Carlsbad, CA, USA); Flag-M2 (Stratagene Inc., La Jolla, CA, USA). AG1478 and PD168393 were purchased from Calbiochem (San Diego, CA, USA). Recombinant human E-cadherin/Fc chimera (hE-Cad/ Fc) was purchased from R&D systems, Inc. (Minneapolis, MN, USA).
